"numinus wellness"

CORRECTION FROM SOURCE: BTV Examines the Rapidly Expanding Psychedelics Market

On Sun. Aug. 22nd at 5pm EST broadcast on FOX Business News — BTV-Business Television explores the burgeoning sector that has captured the attention of investors - psychedelics.


Discover Companies to Invest In - Click company name to watch their TV feature:

Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) — Researching and developing DMT, one of the most powerful psychedelics in existence, to address substance use disorders related to nicotine, alcohol, and opioids. Elemer Piros, Analyst at Roth Capital Partners, weighs in.

Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) — BTV reports on their pre-clinical studies underway with a proprietary extract from the Amanita Muscaria mushroom.

Small Pharma Inc. (TSXV: DMT) — BTV learns about DMT, a psychedelic that is the subject of a Small Pharma clinical trial dealing with depression — the world's first.

Numinus Wellness Inc. (TSXV: NUMI) — BTV checks in with a company at the forefront of a new and innovative mental health treatment focused on psychedelic assisted psychotherapy.

Mydecine Innovations Group (NEO: MYCO) (OTC Pink: MYCOF) — BTV discovers how this company is developing psilocybin-based psychedelic treatments to better address the affects of addiction and post traumatic stress disorder.

On air for over 20 years, BTV - Business Television, a half-hour investment TV show, features analysts and emerging publicly traded companies at their location. With Hosts, Taylor Thoen and Jessica Katrichak, BTV provides viewers with investment opportunities.

Suggest a Company to Feature!
Contact: (604) 664-7401 x3 info@b-tv.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/92856

News Provided by Newsfile via QuoteMedia

Numinus

Numinus Investor Kit

  • Corporate info
  • Insights
  • Growth strategies
  • Upcoming projects

GET YOUR FREE INVESTOR KIT

The Conversation (0)
Numinus

Numinus

Innovative Research into Psychedelic Therapies

Innovative Research into Psychedelic Therapies Keep Reading...
Cannabis buds on a wooden surface with Australian banknotes nearby.

Australia's Cannabis Import Quota Slashed Amid Surging Local Production

Australia’s Office of Drug Control (ODC) said the country’s 2025 cannabis import quota has been reduced by the International Narcotics Control Board from 101 tonnes to 88 tonnes, Business of Cannabis reported.Over-projected demand and idle permits that limited operational flexibility were cited... Keep Reading...
Gavel resting on cannabis leaves.

Cannabis Crossroads: Record US Demand Meets Federal Gridlock

The US cannabis industry is at a turning point. State-level legalization and retail growth continue to accelerate, but federal policy remains stalled, leaving businesses navigating both opportunity and uncertainty. Record consumer demand is driving sales, yet outdated regulations, restrictive... Keep Reading...
Cannabis leaf.

10 Biggest Cannabis Stocks in the US and Canada in 2025

After initial optimism for rescheduling in the US, the cannabis market has faced challenges in 2025. Despite signs of support from US President Donald Trump and members of his administration, regulatory uncertainty persists in the US. Companies are shifting focus to match changes in consumer... Keep Reading...
Field of cannabis plants under bright sunlight.

Cannabis Market Update: H1 2025 in Review

The first half of 2025 played out differently than many cannabis market participants expected. Heading into the year, there was optimism that rescheduling in the US would reduce or eliminate challenges, but the industry continued to grapple with persistent federal regulatory uncertainty,... Keep Reading...
Closeup of lush green cannabis leaves.

Thailand Reverses Course on Cannabis, Moves to Recriminalize Amid Political Fallout

Thailand’s groundbreaking experiment with cannabis decriminalization is rapidly unraveling, with the government formally moving to reclassify the plant as a narcotic and ban recreational sales.The decision has sent shockwaves through an industry once projected to be worth over US$1 billion.The... Keep Reading...
Cannabis leaf over map of Australia.

A State-by-State Guide to Cannabis in Australia

Australia federally legalised medicinal cannabis in 2016, and Australia's cannabis market has seen major growth since then.Medical cannabis approvals were up by 120 percent in the first half of 2023 compared to the same period in 2022. Statista forecasts that Australian cannabis revenue will... Keep Reading...
Numinus

Numinus Investor Kit

  • Corporate info
  • Insights
  • Growth strategies
  • Upcoming projects

GET YOUR FREE INVESTOR KIT

Latest Press Releases

Related News